Molecular mechanisms of IGF-I deficiency

Hormone Research

Volumn 65, Issue SUPPL. 1, 2006, Pages 15-20

  Rosenfeld, Ron G ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

BLOOD ANALYSIS; BLOOD SAMPLING; CELL MEMBRANE; DIAGNOSTIC TEST; DIMERIZATION; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GROWTH DISORDER; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HUMAN; INSULIN LIKE GROWTH FACTOR 1 DEFICIENCY; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE DELETION; GROWTH DISORDERS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; RECEPTORS, SOMATOTROPIN; STAT5 TRANSCRIPTION FACTOR;

EID: 33644615196     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090642     Document Type: Review

References (25)

1. Lupu F, Terwilliger JD, Lee K, Sefre GV, Efstratiadis A: Roles of growth hormone and insulin-like growth factor I in mouse postnatal growth. Dev Biol 2001;229:141-162.
2. Lopez-Bermejo A, Buckway CK, Rosenfeld RG: Genetic defects of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 2000;11:39-49.
3. Rosenfeld RG: Insulin-like growth factors and the basis of growth. N Engl J Med 2004;349:2184-2186.
4. Rosenfeld RG, Hwa V: New molecular mechanisms of GH resistance. Eur J Endocrinol 2004;151:S11-S15.
5. Rosenfeld RG: The molecular basis of idiopathic short stature. Growth Horm IGF Res 2005;15(suppl A):S3-S5.
6. Rosenfeld RG: The IGF system: new developments relevant to pediatric practice. Endocr Dev 2005;9:1-10.
7. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P: A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Gen 2004;36:720-724.
8. Wan Y, McDevitt A, Shen B, Smythe ML, Waters MJ: Increased site 1 affinity improves biopotency of porcine growth hormone. Evidence against diffusion dependent receptor dimerization. J Biol Chem 2004;43:44775-44784.
9. Godowski PJ, leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, et al: Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989;86:8083-8087.
10. Amselem S, Duquesnoy P, Attree O, Nouvelli G, Bousnina S, Postel-Vinay MC, et al: Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 1989;321:989-995.
11. Woods KA, Rosenfeld RG: Abnormalities of growth hormone action. In: Kelnar CJH, Saenger P, Cowell C, Savage MO: Growth Disorders, 2nd edition. London, Hodder Arnold, 2005 (in press).
12. Woods KA, Dastot F, Preece MA, Clark AJ, Postel-Vinay MC, Chatelain PG, et al: Phenotype:genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997;82:3529-3535.
13. Duquesnoy P, Sobrier M-L, Duriez B, Dastot F, Buchanan CR, Savage MO, et al: A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO 1994;13:1386-1395.
14. Ayling RM, Ross R, Towner P, Von Laue S, Finidori J, Moutoussamy S, et al: A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet 1997;16:13-14.
15. Iida K, Takahasji Y, Kahi H, Nose O, Okimura Y, Abe H, et al: Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain. J Clin Endocrinol Metab 1998;83:531-537.
16. Milward A, Metherell L, Maamra M, Barahona MJ, Wilkinson IR, Camacho-Hubner C, et al: Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box 1, resulting in isolated failure of STAT5 signal transduction. J Clin Endocrinol Metab 2004;89:1259-1266.
17. Tiulpakov A, Rubtsov P, Dedov I, Peterkova V, Bezlepkina O, Chrousos GP, et al: A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling. J Clin Endocrinol Metab 2005;90:542-547.
18. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, et al: Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997;94:7239-7244.
19. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, et al: Growth hormone insensitivity (GHI) associated with a STAT-5b mutation. N Engl J Med 2003;349:2728-2736.
20. Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, Ocal G, et al: Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab 2005;90:4260-4266.
21. Domene HM, Bengolea SV, Martinez AS, Ropelato MG, Pennisi P, Scaglia P, et al: Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit. N Engl J Med 2004;350:570-577.
22. Hwa V, Haeusler G, Pratt KL, Little B, Woods KA, Rosenfeld RG: Idiopathic short stature and growth hormone insensitivity (GHI) associated with an absence of acid labile subunit (ALS). 87th Annual Meeting of The Endocrine Society, 2005, p 471.
23. Ueki I, Ooi GT, Tremblay ML, Hurst KR, Bach LA, Boisclair YR: Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci USA 2000;97:6868-6873.
24. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363-1367.
25. Walenkamp MJE, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doom J, Chen JW, et al: Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 2005;90:2855-2864.